Status:
COMPLETED
Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung Biopsy
Lead Sponsor:
University of Arizona
Conditions:
Lesion
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This pilot early phase I trial studies how well real-time optical biopsy works in improving lung cancer diagnosis in patients undergoing lung biopsy. Real-time optical biopsy using confocal microscopy...
Detailed Description
PRIMARY OBJECTIVES: I. Show that it is possible to distinguish lung cancer from benign lesions in ex vivo tissue samples using optical microscopy. II. Test a proof-of-concept endoscopic instrument f...
Eligibility Criteria
Inclusion
- Participants will be drawn from the pool of patients who have suspicious lesions identified on CT and who are already scheduled for a lung biopsy procedure with Dr. Woodhead or one of his colleagues
- Patients will be asked to consent to 2 to 3 extra biopsy samples to be used for this research project
Exclusion
- \- Excluded from this study will be minors below age 18, prisoners, pregnant women, patients with a contraindication for additional lung biopsies, and patients who cannot give informed consent (language barrier, cognitive impairment, etc.)
Key Trial Info
Start Date :
July 26 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 26 2022
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03376971
Start Date
July 26 2017
End Date
April 26 2022
Last Update
October 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Arizona
Tucson, Arizona, United States, 85724